LinkedIn founder launches AI start-up to revolutionize cancer drug discovery
LinkedIn co-founder Reid Hoffman and famed oncologist Dr. Siddhartha Mukherjee have raised a whopping $24.6 million in a seed funding round. The money will be used to launch their new artificial intelligence (AI) start-up, Manas AI.
Reid Hoffman Bets on A.I. Drug Discovery with a Pulitzer-Winning Cancer Physician
Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is expected to generate between $60 billion and $110 billion annually in value for the pharmaceutical and medical-product industries, according to a McKinsey report released last year.
Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.
Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry ...
AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...
Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and ...
ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, ...
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...
With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...
Hosted on MSN14h
Traffic stop leads to drug bust in Port RoyalA routine traffic stop by the Port Royal Police Department (PRPD) led to the discovery and seizure of illegal drugs. At 9:07 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback